– LINZESS® 2023 U.S. net sales of $1.1 billion, an increase of 7% year-over-year, driven by EUTRx prescription demand growth of 10% year-over-year –
– 2023 Ironwood revenue of $443 million,.
HHS officials met with representatives from leading patient advocacy organizations, provider groups, and health insurers to discuss solutions that help guarantee nationwide access to medications that help manage asthma and eosinophilic esophagitis in children.
KATE FARMS PEDIATRIC BLENDED MEALS NOW AVAILABLE tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
Contact: Alicia Reale alicia.reale@uhhospitals.org 216-844-5158 University Hospitals Case Medical Center Researchers from UH Rainbow Babies & Children's Hospital report reasons behind the increase are unclear The largest investigation to date has found a dramatic increase in the number of hospitalizations for children with inflammatory bowel disease (IBD) during the past decade in the United States.…
– Newly published data highlights additional efficacy endpoints from trial –
– Linaclotide is the first and only FDA-approved prescription therapy for children and adolescents aged 6-17 years.